Standout Papers
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial (2015)
- Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial (2016)
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival (2017)
Immediate Impact
4 from Science/Nature 73 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of Matthew Nankivell being referenced
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
2016 Standout
Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew Nankivell | 2305 | 1435 | 1247 | 66 | 3.7k | |
| Dietmar Schmidt | 2039 | 1598 | 1289 | 77 | 5.4k | |
| Karolina Sikorska | 708 | 1247 | 814 | 98 | 2.5k | |
| Antonio Casado | 1403 | 1637 | 2389 | 166 | 5.4k | |
| R. S. Bush | 890 | 718 | 926 | 74 | 3.4k | |
| Andrés Poveda | 2139 | 1267 | 2304 | 154 | 5.6k | |
| Lindsay M. Jacks | 1405 | 822 | 799 | 54 | 2.9k | |
| Ángel J. Lacave | 1224 | 2749 | 1827 | 48 | 5.6k | |
| Amy M. Fremgen | 1155 | 1990 | 1692 | 41 | 4.8k | |
| F. Huguet | 1649 | 1555 | 2726 | 163 | 4.2k | |
| Revathy B. Iyer | 746 | 1502 | 743 | 106 | 3.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...